Article Details

Acorda Therapeutics (NASDAQ:ACOR) Stock Rating Reaffirmed by HC Wainwright

Retrieved on: 2020-01-07 13:03:45

Tags for this article:

Click the tags to see associated articles and topics

Acorda Therapeutics (NASDAQ:ACOR) Stock Rating Reaffirmed by HC Wainwright. View article details on hiswai:

Excerpt

<div><b>Acadian Asset Management</b> LLC boosted its holdings in Acorda Therapeutics by 22.9% in the 2nd quarter. <b>Acadian Asset Management</b> LLC now ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo